BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35106767)

  • 1. Technical note: Low clinical efficacy, but good acceptability of a point-of-care electronic palpation device for breast cancer screening for a lower middle-income environment.
    Valdez D; Cruz T; Rania S; Badowski G; Cassel K; Wolfgruber T; Grosskreutz S; Dulana LJ; Adonay R; Maskarinec G; Shepherd JA
    Med Phys; 2022 Apr; 49(4):2663-2671. PubMed ID: 35106767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of a Hand-Held Scanner for Breast Cancer Early Detection and Patient Triage.
    Clanahan JM; Reddy S; Broach RB; Rositch AF; Anderson BO; Wileyto EP; Englander BS; Brooks AD
    JCO Glob Oncol; 2020 Feb; 6():27-34. PubMed ID: 32031433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Clinical Utility of iBreastExam, a Novel Device, Aid in Optimizing Breast Cancer Diagnosis? A Systematic Review.
    Bhimani F; Zhang J; Shah L; McEvoy M; Gupta A; Pastoriza J; Shihabi A; Feldman S
    JCO Glob Oncol; 2023 Sep; 9():e2300149. PubMed ID: 38085036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol.
    Omisore AD; Olasehinde O; Wuraola FO; Sutton EJ; Sevilimedu V; Omoyiola OZ; Romanoff A; Owoade IA; Olaitan AF; Kingham TP; Alatise OI; Mango VL
    PLoS One; 2023; 18(6):e0284341. PubMed ID: 37310983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.
    Domingo L; Romero A; Blanch J; Salas D; Sánchez M; Rodríguez-Arana A; Ferrer J; Ibáñez J; Vega A; Laso MS; Castells X; Sala M
    Cancer Epidemiol; 2013 Oct; 37(5):660-5. PubMed ID: 23962702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts.
    Kim SY; Kim MJ; Moon HJ; Yoon JH; Kim EK
    Medicine (Baltimore); 2016 Nov; 95(44):e5279. PubMed ID: 27858896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia.
    Kardinah D; Anderson BO; Duggan C; Ali IA; Thomas DB
    Int J Cancer; 2014 Mar; 134(5):1250-5. PubMed ID: 24037942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effective handheld breast scanner for use in low-resource environments: a validation study.
    Broach RB; Geha R; Englander BS; DeLaCruz L; Thrash H; Brooks AD
    World J Surg Oncol; 2016 Oct; 14(1):277. PubMed ID: 27793162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.